Explore the latest innovations in protein research with Bio-Techne's 2024 Virtual Event Series as part of a 12-month campaign to educate and collaborate with members of the biotechnology industry regarding impactful breakthroughs and new insights for protein analysis research.
MINNEAPOLIS, Oct. 9, 2024 /PRNewswire-PRWeb/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the launch of a virtual event series titled "The Simple Way to Advance Protein Research." The first session, Revolutionizing Quantitative Bioanalytical Testing: The Next Leap in Simple Western Technology, will take place on October 24, 2024, at 8:00 AM PDT.
This 12-month virtual event series is designed to provide scientists and researchers with insights into the future of protein research, showcasing Bio-Techne's cutting-edge automated solutions. Attendees will learn how these technologies streamline protein analysis, producing fast, precise, and fully quantitative results in a fraction of the time compared to traditional techniques like western blotting and other immunoassays.
The upcoming webinar will introduce the newest member of the Simple Western™ family—the Leo™ System, a revolutionary platform poised to transform western blots into robust, quantitative bioanalytical methods. this session will highlight how the Leo System is making significant advancements in protein expression analysis.
Webinar Highlights:
- An overview of Simple Western Technology and its application in modern bioanalytical testing.
- How Leo enhances speed and accuracy in multi-sample analysis.
- The transformation of western blots into quantitative measures that reduce errors and variability, providing analytical-grade quantification.
Speaker:
- Chris Heger, PhD, Director, Applications Science, Bio-Techne. See the full abstract here.
For more information about the event and to register for free, click here.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.
About Labroots
Labroots is the leading scientific social networking website, & primary source for scientific trending news & premier educational virtual events & webinars & more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks & communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration & learning. Offering more than articles & webcasts that go beyond the mundane & explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars & virtual events.
Media Contact
Akshay Masand, Labroots, 714.463.4673, [email protected], https://www.labroots.com/
SOURCE Labroots
Share this article